Immunity to COVID-19

Tests in macaques show robust protection against the SARS-CoV-2 virus induced by either vaccines or natural infection.

Photograph by iStock

One of the most clinically significant scientific questions about SARS CoV-2 is whether the human immune system can protect against the disease, as the result of either vaccination or the body’s response to natural infection. 

A pair of studies in macaques, which share 93 percent of their DNA with humans, suggests that exposure to the disease or administration of a vaccine can confer protective immunity. “Our findings increase optimism that the development of COVID-19 vaccines will be possible,” said professor of medicine and of immunology Dan Barouch, senior author of both Science papers. The results are being hailed by other scientists as extremely good news. 

In the study of natural infection, the researchers exposed nine macaques to SARS-CoV-2. All recovered and developed antibodies. Five weeks later, the macaques were again exposed to the virus. This time, the animals displayed rapid immunologic control of the infection, and developed no clinically observable symptoms.

In the vaccination study, Barouch and colleagues in his Beth Israel Deaconess Medical Center laboratory tested six DNA vaccines, designed to instruct the immune system to recognize the SARS-CoV-2 virus that causes COVID-19 disease. (DNA vaccines have not traditionally been viewed as optimal platforms for human vaccine development, and are just one of many approaches being pursued worldwide.) Each vaccine was slightly different: one encoded the full sequence of the spike protein that the virus uses to enter human cells; another did the same, but deleted the cytoplasmic tail; others encoded for different fragments of the spike protein.

The researchers found that all the vaccines, delivered as an initial shot followed by a booster, conferred protection, but some were more effective than others. Furthermore, they discovered that animals that developed higher numbers of antibodies after vaccination also exhibited lower levels of virus after subsequent exposure to SARS-CoV-2. This means that measuring the antibody response could provide clues to the effectiveness of vaccines during clinical testing.

Still unclear is the durability of human immunity to this coronavirus. “Further research will be needed to address the important questions about the length of protection,” said Barouch, “as well as the optimal vaccine platforms for SARS-CoV-2 vaccines for humans.” 

Read more articles by: Jonathan Shaw

You might also like

“It’s Tournament Time”

Harvard women’s basketball prepares for Ivy Madness.

A Harvard Agenda Shaped by Speech

The work underway in the Faculty of Arts and Sciences

Dialogue, not Debate

American University’s Lara Schwartz, J.D. ’98, teaches productive disagreement.

Most popular

alt text here

AWOL from Academics

Behind students' increasing pull toward extracurriculars

Lola Mullaney, Coach Carrie Moore, and Elena Rodriguez

“It’s Tournament Time”

Harvard women’s basketball prepares for Ivy Madness.

View of Harvard University campus from the Charles River

Why Americans Love to Hate Harvard

The president emeritus on elite universities’ academic accomplishments—and a rising tide of antagonism

More to explore

Winthrop Bell

Brief life of a philosopher and spy: 1884-1965

Talking about Talking

Fostering healthy disagreement

A Dogged Observer

Novelist and psychiatrist Daniel Mason takes the long view.